Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease

Bone Marrow Transplantation

Volumn 48, Issue 4, 2013, Pages 502-507

  Reubsaet, L L ^a   De Pagter, A P J ^b   Van Baarle, D ^a   Keukens, L ^b   Nanlohy, N ^a   Sanders, E A M ^a   Prakken, B J ^a   Boelens, J J ^a   De Kleer, I M ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

children; FOXP3; GVHD; hematopoietic SCT; reconstitution

Indexed keywords

BUSULFAN; CYCLOSPORIN A; KI 67 ANTIGEN; PREDNISOLONE; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ALLOREACTIVE DISEASE; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IDIOPATHIC PULMONARY SYNDROME; IMMUNOPATHOLOGY; INFANT; LUNG DISEASE; LYMPHOCYTE COUNT; MALE; MATCHED SIBLING DONOR; MATCHED UNRELATED DONOR; MYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; UNRELATED CORD BLOOD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; KI-67 ANTIGEN; MALE; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84876412446     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.174     Document Type: Article

References (39)

1. Atkinson K, Turner J, Biggs JC, Dodds A, Concannon A. An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium. Bone Marrow Transplant 1991; 8: 231-234.
2. Morris ES, Hill GR. Advances in the understanding of acute graft-versus-host disease. Br J Haematol 2007; 137: 3-19.
3. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340-352.
4. Ferrara JL, Levine JE. Graft-versus-host disease in the 21st century: new perspectives on an old problem. Semin Hematol 2006; 43: 1-2.
5. Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006; 108: 1291-1297.
6. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4( + ) CD25( + ) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389-399.
7. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4( + )CD25( + ) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401-406.
8. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-21.
9. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
10. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells. Nat Immunol 2003; 4: 330-336.
11. Tang Q, Bluestone JA. The Foxp3 + regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9: 239-244.
12. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S et al. CD4 +CD25 + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9: 1144-1150.
13. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4( + )CD25( + ) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493-3499.
14. Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea III EP et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 2011; 365: 2055-2066.
15. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
16. Gaziev J, Isgro A, Marziali M, Daniele N, Gallucci C, Sodani P et al. Higher CD3( + ) and CD34( + ) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia. Bone Marrow Transplant 2012; 47: 107-114.
17. Matthews K, Lim Z, Afzali B, Pearce L, Abdallah A, Kordasti S et al. Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Haematologica 2009; 94: 956-966.
18. Fondi C, Nozzoli C, Benemei S, Baroni G, Saccardi R, Guidi S et al. Increase in FOXP3 + regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant 2009; 15: 938-947.
19. Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J et al. Altered regulatory T cell homeostasis in patients with CD4 + lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest 2010; 120: 1479-1493.
20. Magenau JM, Qin X, Tawara I, Rogers CE, Kitko C, Schlough M et al. Frequency of CD4( + )CD25(hi)FOXP3(+ ) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant 2010; 16: 907-914.
21. Pastore D, Delia M, Mestice A, Carluccio P, Perrone T, Gaudio F et al. CD3( + )/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011; 18: 887-893.
22. Olkinuora H, Talvensaari K, Kaartinen T, Siitonen S, Saarinen-Pihkala U, Partanen J et al. T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 149-156.
23. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
24. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601-1606.
25. Tiercy JM. Molecular basis of HLA polymorphism: implications in clinical transplantation. Transpl Immunol 2002; 9: 173-180.
26. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JK, O'Gorman MR. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000; 7: 336-343.
27. Komanduri St KV, John LS, de LM, McMannis J, Rosinski S, McNiece I et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110: 4543-4551.
28. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
29. Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S et al. Reduced frequency of FOXP3 + CD4 + CD25 + regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005; 106: 2903-2911.
30. Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007; 9: 111-122.
31. Geddes M, Storek J. Immune reconstitution following hematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2007; 20: 329-348.
32. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4 + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007; 110: 2983-2990.
33. De Roock S, Hoeks SB, Meurs L, Steur A, Hoekstra MO, Prakken BJ et al. Critical role for programmed death 1 signaling and protein kinase B in augmented regulatory T-cell induction in cord blood. J Allergy Clin Immunol 2011; 128: 1369-1371.
34. Miyagawa Y, Kiyokawa N, Ochiai N, Imadome K, Horiuchi Y, Onda K et al. Ex vivo expanded cord blood CD4 T lymphocytes exhibit a distinct expression profile of cytokine-related genes from those of peripheral blood origin. Immunology 2009; 128: 405-419.
35. de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP et al. Auto-logous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25 + immune regulatory network. Blood 2006; 107: 1696-1702.
36. Apostolou I, Sarukhan A, Klein L, von BH. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3: 756-763.
37. Cozzo C, Larkin III J, Caton AJ. Cutting edge: self-peptides drive the peripheral expansion of CD4 + CD25 + regulatory T cells. J Immunol 2003; 171: 5678-5682.
38. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA et al. Thymic selection of CD4 + CD25 + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2: 301-306.
39. Selvaraj RK, Geiger TL. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 2007; 178: 7667-7677.